Navigation Links
Vapotherm® Announces FDA Clearance for Precision Flow® Heliox System
Date:10/27/2011

STEVENSVILLE, Md., Oct. 27, 2011 /PRNewswire-USNewswire/ -- Vapotherm announced today receiving FDA clearance for Precision Flow® Heliox, a high flow humidification system designed specifically for use with blended helium oxygen gas mixtures (Heliox).  The product is part of Vapotherm's High Flow Specialty Gas Program for optimal conditioning of breathing gases. Heliox is used in a variety of respiratory applications such as upper airway obstruction, asthma, croup and COPD. "We are pleased to receive clearance for the new Precision Flow® Heliox system, the first high flow device developed specifically for use with this specialty gas," said Bill Niland, Chief Business Development Officer at Vapotherm.  "The device provides clinicians with a rapid, easy to use approach to administer heliox via nasal cannula, without the risks of more invasive methods like mechanical ventilation and pressure based therapies."

Vapotherm's High Flow Specialty Gas Program was created to expand High Flow Therapy (HFT®) beyond air and oxygen to other medical and specialty gases.  The Company's flagship platform device, the Precision Flow, was developed with a modular design concept to allow for several specialty applications in neonatal, pediatric and adult patient populations. In all applications, the device optimizes the delivery of gases via precise blending, flow control, humidification and temperature management.  As with all Vapotherm HFT® products, the overall goal is non-invasive respiratory support via simple nasal cannula in a device that is easy for clinicians to operate but comprehensive in terms of safety and performance features.

Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and home care use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung and acute breathing disorders. For more information, visit www.vtherm.com.

Contact: Kevin Thibodeau, Executive Vice President of Sales and Marketing

410-604-3977


'/>"/>
SOURCE Vapotherm, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vapotherm® Receives FDA 510(k) Clearance for Flowrest® Homecare Device
2. China Kanghui Holdings Announces Participation in Upcoming Investor Conferences
3. Ground Zero Pharmaceuticals, Inc. (GZP) Announces Expansion of Oncology Programs for Its Clients
4. Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2011 Financial Results and Announces Presentations at the American Association for the Study of Liver Diseases Meeting (AASLD)
5. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2011 Financial Results
6. CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies
7. Global Pharm Announces the Closing of US$15 Million Redeemable Convertible Bonds Financing
8. Intellect Neurosciences Announces Its New CONJUMAB-A Platform Technology for Novel Treatments of Alzheimers Disease and Other Proteinopathies
9. Perrigo Company Announces Quarterly Dividend
10. MiMedx Group Announces Third Quarter 2011 Results
11. Anthera Announces Last Patient Enrolled in PEARL-SC Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market ... has covered and analysed the potential of Global Effective Microorganisms ... shares and growth factors. The report identifies and analyses the ... the global market. ... 152 Tables and Figures, 6 Major Company Profiles, spread across ...
(Date:4/19/2017)... -- Companion animal vaccines are ... such as canine, avian and feline. ... as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, ... Vaccines. Attenuated live vaccines are derived from disease-causing ... been weakend under laboratory conditions. Conjugate vaccines are ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn more about ... ) that demonstrates how this advanced plant breeding technology is a more efficient ... fewer resources. It highlights the business’ principles, research and collaboration efforts in this ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Mirroring360 Pro . This new addition to the Mirroring360 product family combines ... and business. , Mirroring360 Pro enables educators, business professionals and individuals to stream ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report ... score performance for the 2015-16 school year across Wisconsin’s public schools, charter schools, ... highlights important patterns in student test score performance, the report’s limited analyses fail ...
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring ... birth defects research related to Zika virus during pregnancy, as well as other ... this important science. , The Teratology Society is an international ...
(Date:4/25/2017)... ... , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will ... set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is ... of Medicine. He also serves as Medical Director for the Bureau of Emergency Medical ...
Breaking Medicine News(10 mins):